Is There an End in Sight to Reproductive Health's Drug Innovation Drought?

Reproductive health is a therapeutic area that has seen too little progress for too long. This article from Inside Reproductive Health details why there has been a drug innovation drought for two decades and what's being done to reimagine what's possible for those on the path to parenthood. It starts with collective commitment—developers investing in discovery, investors recognizing value, and companies willing to hazard the risk, time, and money to introduce new therapies. Read more here.